Caplight Directory>Companies>NEX-I, Inc.-preview>Nex-i-co


NEX-I, Inc.

NEX-I, Inc.

Private
SeoulHealthcare & Life Scienceshttp://www.nex-i.co.kr

Last Round

Series B

Aug 12, 2025

Est. Valuation

$43.27M

Total Funding Raised

$64.03M

Company Overview

NEX-I, Inc. is a biotechnology company that develops next-generation immunotherapeutics to overcome resistance to cancer treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

AI video analysisvideo analyticssmart citytraffic analysisintelligent transport systemITSpublic safetycomputer visionfacial recognitionGovTechCCTV analysisincident detectionB2Gvideo management systemsmart intersections

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NEX-I, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NEX-I, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BAug 12, 2025
Series AOct 7, 2022
Pre SeedDec 22, 2021
View all Funding Rounds

NEX-I, Inc. Investors

Notable investors and investment history

InvestorRounds
Hana VenturesPre Seed, Series A, Series B
DSC InvestmentPre Seed, Series B, Series A
K2 Investment PartnersSeries B
KB InvestmentSeries B
TS InvestmentSeries A, Series B
QUAD Investment ManagementSeries B
Company K PartnersSeries B
View all Investors

NEX-I, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NEX-I, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NEX-I, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range4
Year Founded2021
Last FundingAug 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.